<SEC-DOCUMENT>0001123292-25-000364.txt : 20250814
<SEC-HEADER>0001123292-25-000364.hdr.sgml : 20250814
<ACCEPTANCE-DATETIME>20250814105843
ACCESSION NUMBER:		0001123292-25-000364
CONFORMED SUBMISSION TYPE:	13F-HR
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250814
DATE AS OF CHANGE:		20250814
EFFECTIVENESS DATE:		20250814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GILEAD SCIENCES, INC.
		CENTRAL INDEX KEY:			0000882095
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				943047598
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		13F-HR
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	028-25078
		FILM NUMBER:		251215566

	BUSINESS ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6505743000

	MAIL ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILEAD SCIENCES INC
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>13F-HR
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns="http://www.sec.gov/edgar/thirteenffiler">
  <schemaVersion>X0202</schemaVersion>
  <headerData>
    <submissionType>13F-HR</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <filer>
        <credentials>
          <cik>0000882095</cik>
          <ccc>XXXXXXXX</ccc>
        </credentials>
      </filer>
      <periodOfReport>06-30-2025</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <reportCalendarOrQuarter>06-30-2025</reportCalendarOrQuarter>
      <isAmendment>false</isAmendment>
      <filingManager>
        <name>GILEAD SCIENCES, INC.</name>
        <address>
          <com:street1>333 LAKESIDE DR</com:street1>
          <com:city>FOSTER CITY</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94404</com:zipCode>
        </address>
      </filingManager>
      <reportType>13F HOLDINGS REPORT</reportType>
      <form13FFileNumber>028-25078</form13FFileNumber>
      <provideInfoForInstruction5>N</provideInfoForInstruction5>
    </coverPage>
    <signatureBlock>
      <name>Andrew D. Dickinson</name>
      <title>Executive Vice President and Chief Financial Officer</title>
      <phone>650-574-3000</phone>
      <signature>/s/ Andrew D. Dickinson</signature>
      <city>FOSTER CITY</city>
      <stateOrCountry>CA</stateOrCountry>
      <signatureDate>08-14-2025</signatureDate>
    </signatureBlock>
    <summaryPage>
      <otherIncludedManagersCount>1</otherIncludedManagersCount>
      <tableEntryTotal>14</tableEntryTotal>
      <tableValueTotal>1280204668</tableValueTotal>
      <otherManagers2Info>
        <otherManager2>
          <sequenceNumber>1</sequenceNumber>
          <otherManager>
            <cik>0002055207</cik>
            <form13FFileNumber>028-25083</form13FFileNumber>
            <name>Gilead Therapeutics A1 Unlimited Co</name>
          </otherManager>
        </otherManager2>
      </otherManagers2Info>
    </summaryPage>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>INFORMATION TABLE
<SEQUENCE>2
<FILENAME>informationtable.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="us-ascii"?>
<informationTable xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable">
    <infoTable>
        <nameOfIssuer>ALLOGENE THERAPEUTICS INC</nameOfIssuer>
        <titleOfClass>COM</titleOfClass>
        <cusip>019770106</cusip>
        <value>1307059</value>
        <shrsOrPrnAmt>
            <sshPrnamt>1156689</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>1156689</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>KALARIS THERAPEUTICS INC</nameOfIssuer>
        <titleOfClass>COM</titleOfClass>
        <cusip>482929106</cusip>
        <value>848497</value>
        <shrsOrPrnAmt>
            <sshPrnamt>317789</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>317789</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>ARCELLX INC</nameOfIssuer>
        <titleOfClass>COMMON STOCK</titleOfClass>
        <cusip>03940C100</cusip>
        <value>442564878</value>
        <shrsOrPrnAmt>
            <sshPrnamt>6720803</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>6720803</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>ARCUS BIOSCIENCES INC</nameOfIssuer>
        <titleOfClass>COM</titleOfClass>
        <cusip>03969F109</cusip>
        <value>255797546</value>
        <shrsOrPrnAmt>
            <sshPrnamt>31424760</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>31424760</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>ASSEMBLY BIOSCIENCES INC</nameOfIssuer>
        <titleOfClass>COM NEW</titleOfClass>
        <cusip>045396207</cusip>
        <value>40035615</value>
        <shrsOrPrnAmt>
            <sshPrnamt>2209471</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>2209471</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>GALAPAGOS NV</nameOfIssuer>
        <titleOfClass>SPON ADR</titleOfClass>
        <cusip>36315X101</cusip>
        <value>467642281</value>
        <shrsOrPrnAmt>
            <sshPrnamt>16707477</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>DFND</investmentDiscretion>
        <otherManager>1</otherManager>
        <votingAuthority>
            <Sole>16707477</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>HOOKIPA PHARMA INC</nameOfIssuer>
        <titleOfClass>COM NEW</titleOfClass>
        <cusip>43906K209</cusip>
        <value>2354311</value>
        <shrsOrPrnAmt>
            <sshPrnamt>1875945</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>1875945</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>TANGO THERAPEUTICS INC</nameOfIssuer>
        <titleOfClass>COM</titleOfClass>
        <cusip>87583X109</cusip>
        <value>24854748</value>
        <shrsOrPrnAmt>
            <sshPrnamt>4854443</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>4854443</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>BARINTHUS BIOTHERAPEUTICS PL</nameOfIssuer>
        <titleOfClass>ADS</titleOfClass>
        <cusip>91864C107</cusip>
        <value>92524</value>
        <shrsOrPrnAmt>
            <sshPrnamt>99478</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>99478</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>KYVERNA THERAPEUTICS INC</nameOfIssuer>
        <titleOfClass>COM</titleOfClass>
        <cusip>501976104</cusip>
        <value>12667185</value>
        <shrsOrPrnAmt>
            <sshPrnamt>4126119</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>4126119</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>IKENA ONCOLOGY INC</nameOfIssuer>
        <titleOfClass>COM</titleOfClass>
        <cusip>45175G108</cusip>
        <value>467053</value>
        <shrsOrPrnAmt>
            <sshPrnamt>348534</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>348534</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>XILIO THERAPEUTICS INC</nameOfIssuer>
        <titleOfClass>COM</titleOfClass>
        <cusip>98422T100</cusip>
        <value>6190796</value>
        <shrsOrPrnAmt>
            <sshPrnamt>9105451</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>9105451</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>LEAP THERAPEUTICS INC</nameOfIssuer>
        <titleOfClass>COM NEW</titleOfClass>
        <cusip>52187K200</cusip>
        <value>1579255</value>
        <shrsOrPrnAmt>
            <sshPrnamt>5319148</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>5319148</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
    <infoTable>
        <nameOfIssuer>MERUS N V</nameOfIssuer>
        <titleOfClass>COM</titleOfClass>
        <cusip>N5749R100</cusip>
        <value>23802920</value>
        <shrsOrPrnAmt>
            <sshPrnamt>452527</sshPrnamt>
            <sshPrnamtType>SH</sshPrnamtType>
        </shrsOrPrnAmt>
        <investmentDiscretion>SOLE</investmentDiscretion>
        <votingAuthority>
            <Sole>452527</Sole>
            <Shared>0</Shared>
            <None>0</None>
        </votingAuthority>
    </infoTable>
</informationTable>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
